A case-control study of robot-assisted type III radical hysterectomy with pelvic lymph node dissection compared with open radical hysterectomy

Objective The purpose of this study was to compare robotically assisted hysterectomy (RAH) with open (ORH) type III radical hysterectomy in the treatment of early-stage cervical cancer. Study Design The outcomes of 51 consecutive patients who underwent RAH were compared with the outcomes of 49 patie...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of obstetrics and gynecology Vol. 199; no. 4; pp. 357.e1 - 357.e7
Main Authors Boggess, John F., MD, Gehrig, Paola A., MD, Cantrell, Leigh, MD, Shafer, Aaron, MD, Ridgway, Mildred, MD, Skinner, Elizabeth N., MD, Fowler, Wesley C., MD
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Mosby, Inc 01.10.2008
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective The purpose of this study was to compare robotically assisted hysterectomy (RAH) with open (ORH) type III radical hysterectomy in the treatment of early-stage cervical cancer. Study Design The outcomes of 51 consecutive patients who underwent RAH were compared with the outcomes of 49 patients who underwent ORH. Results There were no differences with regard to patient demographics. There were significant differences between the groups with regard to operative blood loss ( P < .0001), operative time ( P = .0002), and lymph node retrieval ( P = .0003), all of which were in favor of the RAH cohort. All patients with RAH were discharged on postoperative day 1, compared with a 3.2-day average hospitalization for the cohort with ORH. The incidence of postoperative complications was 7.8% and 16.3% for the RAH and ORH cohorts, respectively ( P = .35). Conclusion Robotic type III radical hysterectomy with pelvic node dissection is feasible and may be preferable over open radical hysterectomy in patients with early-stage cervical cancer. Further study will determine procedure generalizability and long-term oncologic outcomes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0002-9378
1097-6868
DOI:10.1016/j.ajog.2008.06.058